Business Description
Vigil Neuroscience Inc
NAICS : 325412
SIC : 2834
Description
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.57 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.18 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.97 | |||||
| 9-Day RSI | 41.4 | |||||
| 14-Day RSI | 43.29 | |||||
| 6-1 Month Momentum % | -45.03 | |||||
| 12-1 Month Momentum % | -31.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.07 | |||||
| Quick Ratio | 19.07 | |||||
| Cash Ratio | 18.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.98 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -43.6 | |||||
| ROA % | -40.32 | |||||
| ROIC % | -767.9 | |||||
| ROC (Joel Greenblatt) % | -908.17 | |||||
| ROCE % | -44.1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.19 | |||||
| Price-to-Tangible-Book | 1.3 | |||||
| EV-to-EBIT | -0.67 | |||||
| EV-to-EBITDA | -0.68 | |||||
| EV-to-FCF | -0.74 | |||||
| Price-to-Net-Current-Asset-Value | 1.49 | |||||
| Price-to-Net-Cash | 1.56 | |||||
| Earnings Yield (Greenblatt) % | -149.25 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VIGL
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vigil Neuroscience Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.04 | ||
| Beta | 0 | ||
| Volatility % | 90.67 | ||
| 14-Day RSI | 43.29 | ||
| 14-Day ATR ($) | 0.829197 | ||
| 20-Day SMA ($) | 5.91475 | ||
| 12-1 Month Momentum % | -31.22 | ||
| 52-Week Range ($) | 4.685 - 16.7699 | ||
| Shares Outstanding (Mil) | 35.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vigil Neuroscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vigil Neuroscience Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vigil Neuroscience Inc Frequently Asked Questions
What is Vigil Neuroscience Inc(VIGL)'s stock price today?
The current price of VIGL is $5.59. The 52 week high of VIGL is $16.77 and 52 week low is $4.68.
When is next earnings date of Vigil Neuroscience Inc(VIGL)?
The next earnings date of Vigil Neuroscience Inc(VIGL) is 2023-11-10 Est..
Does Vigil Neuroscience Inc(VIGL) pay dividends? If so, how much?
Vigil Neuroscience Inc(VIGL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers